Page last updated: 2024-11-07

methyl beta-cellobioside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Methyl beta-cellobioside is a cellobiose derivative that has been studied for its potential applications in various fields, including pharmaceuticals, food science, and biomaterials. It is a disaccharide composed of two glucose units linked by a beta-1,4-glycosidic bond. The methyl group is attached to the anomeric carbon of the reducing end glucose unit. Methyl beta-cellobioside can be synthesized by various methods, including enzymatic transglycosylation, chemical synthesis, and microbial fermentation. It has been shown to possess various biological activities, such as antioxidant, anti-inflammatory, and anti-diabetic properties. Moreover, it has been investigated as a potential building block for the synthesis of biodegradable polymers and other functional materials. The study of methyl beta-cellobioside is driven by its unique structural features, its potential applications in various fields, and its potential for developing novel and sustainable technologies.'

methyl beta-cellobioside: molecular model given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID111276
MeSH IDM0220564

Synonyms (9)

Synonym
7216-73-1
(2s,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxy-oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 4-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
einecs 230-604-1
methyl beta-cellobioside
methyl-beta-d-cellobioside
DTXSID101315510
methyl cellobioside
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]